V
Vida Clinical Research | Vida Dermatology South
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Rocatinlimab
BFB759
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urtic...
Active, not recruiting
Chronic Spontaneous Urticaria
Biological: Matching placebo
Biological: barzolvolimab
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...
Enrolling
Atopic Dermatitis (AD)
Biological: BFB759
Drug: Placebo
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Active, not recruiting
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab
Trial sponsors
B
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems